Literature DB >> 1601030

Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration.

J M Carballido1, N Carballido-Perrig, G Terres, C H Heusser, K Blaser.   

Abstract

Protein antigens with both allergenic and immunoprotective properties represent appropriate molecules to study IgE and IgG regulation. We have established a panel of T cell clones specific to bee venom phospholipase A2 (PLA) from human individuals allergic, hyposensitized or immune (protected) to bee sting. All clones obtained were CD3+, CD4+ and expressed alpha, beta T cell receptor. Depending on the T cell clone, maximal stimulation required 1 to 100 micrograms/ml of PLA, and the addition of interleukin (IL)-2 and/or IL-4 increased their antigen-dependent proliferation. Following antigen stimulation, the clones produced IL-4, interferon-gamma (IFN-gamma) and granulocyte-macrophage colony-stimulating factor. Most clones also produced tumor necrosis factor alpha (TNF-alpha) and tumor necrosis factor beta (TNF-beta), and some produced IL-5 and/or IL-2. Both absolute and relative amounts of secreted cytokines depended on the antigen concentration. At low antigen doses, IL-4 was produced but little or not IFN-gamma, whereas at higher PLA concentrations significant amounts of both IL-4 and IFN-gamma were obtained. Thus, these PLA-specific T cell clones could be classified according to the changes in the ratio of IL-4/IFN-gamma production in response to increasing antigen concentrations. Clones derived from allergic and hyposensitized individuals required higher critical amounts of antigen for IFN-gamma induction, and expressed increasing IL-4/IFN-gamma ratios with increasing concentrations of PLA. Modulation of cytokine patterns by the dose of the antigen may be a driving force for IgE or IgG formation resulting in allergy or immunoprotection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601030     DOI: 10.1002/eji.1830220605

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

Review 1.  Hymenoptera venom allergens.

Authors:  Donald R Hoffman
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

2.  CD4+ T-helper-cell responses in mice with low-level Candida albicans infection.

Authors:  A Mencacci; R Spaccapelo; G Del Sero; K H Enssle; A Cassone; F Bistoni; L Romani
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

3.  [Allergen specific immunotherapy for rhinitis allergica : New applications].

Authors:  L Klimek; T Kündig; G Senti
Journal:  HNO       Date:  2015-05       Impact factor: 1.284

Review 4.  Normal and atopic IgE responses.

Authors:  R H Zubler; X Zhang; A Tucci; B S Polla; C Werner-Favre
Journal:  Springer Semin Immunopathol       Date:  1993

Review 5.  Novel approaches in immunotherapy.

Authors:  J M Saint-Remy
Journal:  Clin Rev Allergy       Date:  1994

6.  A recombinant BCG vaccine generates a Th1-like response and inhibits IgE synthesis in BALB/c mice.

Authors:  M Kumar; A K Behera; H Matsuse; R F Lockey; S S Mohapatra
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

7.  Antagonism of airway tolerance by endotoxin/lipopolysaccharide through promoting OX40L and suppressing antigen-specific Foxp3+ T regulatory cells.

Authors:  Wei Duan; Takanori So; Michael Croft
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

8.  Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.

Authors:  C A Akdis; M Akdis; T Blesken; D Wymann; S S Alkan; U Müller; K Blaser
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

9.  T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis.

Authors:  B Chauhan; A p Knutsen; P S Hutcheson; R G Slavin; C J Bellone
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

Review 10.  Regulatory tone and mucosal immunity in asthma.

Authors:  Timothy J Chapman; Steve N Georas
Journal:  Int Immunopharmacol       Date:  2014-06-25       Impact factor: 4.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.